33 results on '"Shah, Ashu"'
Search Results
2. Pancreatic Cancer: Pursuit of Mucins from Progression to Prognosis
3. Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma
4. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma
5. Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies
6. MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR
7. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma
8. Cancer Metabolism and Aggressive Tumor Behavior
9. DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis
10. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics
11. Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications
12. Liquid Biopsies for Pancreatic Cancer: A Step Towards Early Detection
13. Programmed Death 1 Receptor (PD-1)-mediated Immunomodulatory Effects in Pancreatic Cancer
14. Figure S1 from A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
15. Table S1 from A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
16. Data from A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
17. A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
18. Data from MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion
19. Supplementary Figure from MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion
20. Supplementary Table from MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion
21. Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma
22. Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer
23. MUC16 promotes Triple-Negative Breast Cancer Lung Metastasis by Modulating RNA- Binding Protein ELAVL1/HUR
24. MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion
25. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma
26. The Current Landscape of Antibody-based Therapies in Solid Malignancies
27. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness
28. Abstract 2289: Evaluation of novel genetically engineered anti-MUC16 antibody for therapeutic targeting in pancreatic cancer
29. Abstract 4438: Role of post translational modification of PAF1/PD2 in gemcitabine resistance of pancreatic cancer
30. MUC16 as a novel target for cancer therapy
31. Effect of Organic Solvents on the Molten Globule State of Procerain: β-Sheet to α-Helix Switchover in Presence of Trifluoroethanol
32. Effect of Organic Solvents on the Molten Globule State of Procerain: -Sheet to -Helix Switchover in Presence of Trifluoroethanol
33. Effect of organic solvents on the molten globule state of procerain: beta-sheet to alpha-helix switchover in presence of trifluoroethanol.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.